INTRODUCTION
============

Leveraging the Internet-of-things (IoT) infrastructure to transform personalized and precision medicine necessitates the large-scale deployment of health and wellness monitoring sensors in readily proliferated, wearable consumer electronics to harvest physiologically relevant data with minimal user intervention ([@R1], [@R2]). To this end, physical sensors have been widely incorporated within commercialized wearable platforms to track the users' physical activities and vital signs ([@R3]--[@R7]). However, to gain insight into the body's dynamic chemistry, electrochemical sensing interfaces are required to target the biomarker molecules present in noninvasively retrieved biofluids such as sweat. To this end, enzymatic, ion-selective, and electroactive electrochemical sensing interfaces were previously developed to target informative analytes such as metabolites and electrolytes ([@R8]--[@R13]). These sensing interfaces were embedded within sophisticated epidermal microfluidic configurations ([@R11]) and interfaced with wireless circuit boards to achieve system-level functionality ([@R14], [@R15]). However, such implementations, for the most part, focused on optimizing the individual modules separately. Existing systems rely on in-plane interconnections and rigid connectors, fundamentally forcing them to route the transduced signal from the sensor to the readout electronics through highly strained (motion-induced) regions ([@R16]--[@R18]). This limitation makes them severely susceptible to device operation failure (due to delamination, slipping, detachment, metal interconnect cracking, etc.) and external interference (e.g., mechanical noise), both of which lead to the loss of data fidelity ([@R19], [@R20]). Body motion restriction and/or external fixtures were required to stabilize and communicate the readings, making reported techniques impractical for the envisioned wearable applications.

To achieve high-fidelity biomarker data acquisition, careful understanding and subsequently engineering the information delivery pathway from the skin to a readout unit is critical. Unlike the wearable physical sensors harvesting information from direct contact with the epidermis, the electrochemical sensors need to directly interact with the epidermally retrieved biofluid to target biomarker data. This difference in the target information medium fundamentally necessitates a different design rationale and methodology. As shown in [Fig. 1A](#F1){ref-type="fig"}, for electrochemical sensing, the information delivery pathway consists of sampling and delivering the biomarker-rich biofluid to the sensor surface within a microfluidic structure, followed by signal transduction at the sensor surface and signal routing to the readout electronics via interconnecting elements (e.g., metal traces and sensor-circuit connector). To preserve the fidelity of the biomarker information, the signal must be preserved along this pathway in the presence of motion-induced strain.

![FESS design rationale, implementation, and application.\
(**A**) Schematic of the biomarker information delivery pathway enabled by the FESS, illustrating sampling, sensing, and routing of epidermally retrieved biomarker information to readout electronics through a single entity. (**B**) Design rationale of the FESS. (**C**) Representative implementation of the FESS, demonstrating flexibility and no in-plane interconnection. (**D**) Representative family of FESS devices, containing 1 × 2, 3 × 3, and 6 × 6 electrode arrays. (**E**) Custom-developed and FESS-enabled smartwatch for biomarker monitoring. (**F** and **G**) Deployment of the FESS-enabled smartwatch in stationary (F) and high-intensity exercise (G) settings. (Photo credit: Peterson Nguyen, Kaili Chiu, Yichao Zhao, University of California, Los Angeles.)](aaz0007-F1){#F1}

Here, by examining the biomarker information delivery pathway and recognizing near-zero strained regions within a microfluidic-based sensing module ([@R21], [@R22]), we engineer a strain-isolated pathway to preserve the biomarker data fidelity. Accordingly, a generalizable and disposable freestanding electrochemical sensing system (FESS) is devised, which simultaneously facilitates sensing and out-of-plane signal interconnection with the aid of double-sided adhesion. The FESS can be simultaneously adhered to skin and electronics with the aid of double-sided adhesion forces and without the need for rigid connectors. As a standalone unit, the FESS samples and directs epidermally retrieved biofluids (e.g., sweat) for electrochemical sensing. Then, it routes the transduced signal to the readout electronics through a strain-isolated pathway with the aid of out-of-plane interconnection.

On a broader scope, the FESS can serve as a foundation to realize an unprecedented system-level design strategy to address the challenges of wearable biosensing and integration with consumer electronics for daily use. To illustrate this point, the FESS was integrated within a custom-developed smartwatch to render a self-contained and skin-mountable wearable platform capable of sweat induction, sampling, electrochemical sensing, signal processing, and data display/transmission. The FESS-enabled smartwatch was specifically used to monitor the sweat metabolite profiles of individuals engaged in various daily activities. The results indicate that the devised FESS-enabled platform renders high-fidelity signal transduction as well as robust mechanical contact with human skin without constraining user motion. This freestanding sensing system can be integrated with the future wearable consumer electronics to generate high-fidelity longitudinal health- and wellness-related datasets throughout the users' daily activities.

RESULTS
=======

Design principles of the FESS
-----------------------------

Careful examination of the strain distribution of a typical microfluidic module, under motion-induced stress, yields near-zero strain at the bottom of the microfluidic channel (channel-biofluid interface). The resultant strain profile can be attributed to the absorption and isolation of the strain by the load-bearing components of the microfluidic structure and biofluid, respectively. As shown in [Fig. 1B](#F1){ref-type="fig"}, by recognizing and leveraging the fact that the strain-isolated region is the one that contains the sensor, we engineer a strain-isolated biomarker information delivery pathway that protects and routes the signal from the biofluid sensing interface all the way to the readout electronics.

To render an efficient pathway, we were inspired by integrin, a cell adhesive molecule, which efficiently enables physiological information exchange between intracellular (e.g., cytoskeleton) and extracellular matrices ([@R23], [@R24]). As a single entity, integrin uses double-sided adhesion forces (e.g., van der Waals force) to facilitate sensing and out-of-plane signal interconnection (fig. S1A). Accordingly, a generalizable and disposable FESS is devised, which implements integrin-like functionalities through a strain-isolated region within a microfluidic structure (fig. S1B).

The FESS is engineered as a vertically conductive, double-sided adhesive, and flexible microfluidic bioanalytical thin film system (figs. S2 and S3). This thin film system consists of multiple vertically stacked films: an adhesive anisotropic conductive film (ACF), a noble metal electrode array film, a biochemical film, a microfluidic film (fig. S4, A to E) ([@R25], [@R26]), and a skin adhesive film. The versatility of the FESS in terms of its core capabilities is demonstrated by depositing various patterns of different noble metals \[gold, Au, and platinum (Pt)\] as well as different sensing layers to target a panel of physiologically relevant biomarker molecules in sweat. The inherent vertical conductivity of the FESS based on ACF allows for the realization of out-of-plane interconnection ([Fig. 1C](#F1){ref-type="fig"}), which provides a degree of freedom for signal routing to avoid highly strained regions, thus preserving the transduced signal along the sensor-to-electronics signal pathway. The vertical conductivity and adhesive properties of the FESS, together, allow for direct interface with contact pads (fig. S4F) on the readout electronics, eliminating the need for rigid connectors. In addition, by including a microfluidic film, the thin film and inherently flexible system can be adapted for leakage-free epidermal biofluid (e.g., sweat) harvesting and routing (figs. S4, G to K, and S5). The FESS can be adhered to skin and electronics by leveraging its double-sided adhesive property.

As a complete thin film system, it can be simply taped onto the readout electronics without the need for any connectors and with minimal contact resistance, thus potentially transforming any electrical contact into a chemo-/biosensor. The versatility of the FESS design allows for its implementation in various array formats (e.g., 1 × 2, 3 × 3, and 6 × 6, as exemplified in [Fig. 1D](#F1){ref-type="fig"}) to satisfy the end-application requirements. A representative, self-contained biomarker sensing smartwatch, realized with the aid of FESS, is shown in [Fig. 1E](#F1){ref-type="fig"}, which can monitor the sweat metabolite profiles of individuals in sedentary ([Fig. 1F](#F1){ref-type="fig"}) and high-intensity exercise settings ([Fig. 1G](#F1){ref-type="fig"}).

A strain-isolated signal pathway
--------------------------------

In this section, we first demonstrate the underlying physical phenomenon governing the superior performance of the out-of-plane (achieved by FESS) versus conventional in-plane signal interconnection. Then, we characterize the out-of-plane electrical interconnection and mechanical adhesion properties of the FESS.

Conventional, wearable microfluidic electrochemical sensors rely on in-plane signal interconnection ([Fig. 2A](#F2){ref-type="fig"}) to relay the transduced signals to the readout circuitry. Therefore, on the basis of the implemented signal pathways, the signal is inevitably routed through body motion--induced strain-concentrated regions \[including the two-dimensional (2D)--patterned interconnects and/or the connector; fig. S6, A to C\]. Accordingly, they are severely susceptible to device operation failure (due to delamination, slipping, detachment, metal interconnect cracking, etc.) and interference (e.g., strain-induced noise), both of which lead to the loss of data fidelity.

![FESS strain simulation and characterization of strain-isolated signal interconnection.\
(**A**) Illustration of the FESS' out-of-plane signal interconnection versus conventional in-plane signal interconnection. Conventional implementations are constrained to signal routing through highly strained regions, while the devised FESS allows for routing via near-zero strain regions. (**B**) COMSOL-simulated strain (ε) profile of a representative FESS in the presence of an externally applied shear force, illustrating near-zero strain at the bottom of the microchannel (i.e., substrate-biofluid interface). (**C**) Corresponding zoomed-in view of the strain profile for one "pixel." (**D**) Strain distribution along the dashed line in (C). (**E**) Out-of-plane interconnection electrical characterization of FESS, performed under different localized bending angles (for an array of 6 × 6 Au electrodes). (**F**) Interconnection resistances of the bent FESS-FPCB (*R*~FESS~ + *R*~FPCB~), for different localized bending angles (normalized with respect to *R*~FPCB~ with no bending, *R*~FPCB,0~). Error bars indicate standard error of measurements across the six electrodes within each column. (**G**) Resistance measurements of the FESS electrodes under different bending angles (*n* = 36), in relation to the FPCB contact pad resistance (*R*~FPCB,0~). (**H** to **J**) 180° peeling tests characterizing the interconnection adhesion between the PCB and FESS with different backing structures: microfluidic base--ACF (H), microfluidic channel--ACF (I), and a representative microfluidic channel array--ACF (J). (Photo credit: Peterson Nguyen, University of California, Los Angeles.)](aaz0007-F2){#F2}

In the implementation of the FESS, the inherent vertical conductivity of the ACF facilitates out-of-plane signal interconnection \[[Fig. 2A](#F2){ref-type="fig"}; similar to that shown in the reported advanced stretchable electronics ([@R27])\], which, here, can be exploited as a degree of freedom for avoiding undesired body motion--induced strain effects on signal pathways. To illustrate this point, we simulated the strain profile experienced by a representative FESS ([Fig. 2B](#F2){ref-type="fig"}) under an applied force (representing the force exerted along the skin-device interface due to the body motion). [Figure 2C](#F2){ref-type="fig"} visualizes the corresponding strain distribution of a sensing pixel within the FESS, demonstrating that the maximal strain occurs in the regions where the microfluidic structure contacts with the substrate, while minimal strain occurs at the biofluid-substrate interface (encompassing the sensor). When constructing the signal pathway, the high-strain regions can be avoided by leveraging the out-of-plane interconnection property of the FESS. As shown in [Fig. 2D](#F2){ref-type="fig"}, this unique property of FESS allows for significantly reducing (by two orders of magnitude) the strain experienced by the transduced signals. This strain isolation strategy rendered by FESS can be generally adopted for interfacing electronics with different mechanical properties. Figure S6D shows the simulated strain profiles for electronics with different substrate materials and Young's modulus (also detailed in table S1): stretchable polydimethylsiloxane (PDMS) (500 kPa), flexible polyimide (PI) board (2.5 GPa), and rigid board (24 GPa). In particular, the results shown in fig. S6D indicate that the strain-isolated regions are present in all scenarios (independent of the electronic substrate's stiffness). In addition, the interconnection length rendered by FESS is \~50 μm (corresponding to the thickness of the ACF). This represents more than two orders of magnitude reduction in the transduced signal pathway, as compared with the conventional implementations with centimeter-scale interconnection routing, which is critical to the mitigation of external electromagnetic interference and mechanical noise.

We first establish the suitability of the ACF to simultaneously serve as an electrode supporting substrate and as an interconnection film. To pattern electrodes on ACF, the inherent adhesive property of the ACF was leveraged to directly deposit Au via e-beam metal evaporation. This approach eliminates the need for the metal adhesion layer (e.g., chromium or titanium) and subsequently allows for realizing a corrosion-resistant and stable interface for operation in a biofluid environment ([@R28]).

To demonstrate the robustness of the out-of-plane signal interconnection against mechanical deformation, the FESS-based interconnection resistance distribution (*R*~FESS~) of a representative 6 × 6 grid of Au ACF-based electrodes was characterized under spatially varying strain distribution profiles. Accordingly, the grid of electrodes was mated with a corresponding grid of flexible printed circuit board (PCB)--based contact pads (with resultant resistance distribution *R*~FESS~ + *R*~FPCB~) via adhesion. Then, the resultant configuration was mounted on holders with localized tip radius curvature (α = 60°, *R* = 15 mm and α = 30°, *R* = 10 mm), such that the column 4 of the mated gird configuration experiences the maximal strain, while other columns experience minimal strain (conceptualized in [Fig. 2E](#F2){ref-type="fig"}). By comparison of the *R*~FESS~ measurements of the fourth column with those of other columns, we can evaluate the effect of the stress concentration on the out-of-plane interconnection resistance across the device. Our characterization results, as shown in [Fig. 2F](#F2){ref-type="fig"}, demonstrate that despite the high strain experienced by the fourth column (compared with the others), the corresponding out-of-plane interconnection resistances were minimally affected across the device (for all three tested conditions, i.e., flat, bent at 30°, and bent at 60°). The observed variations are on the order of 5%, which can be attributed to the error associated with the manual probing of the resistance values. The interconnection resistance (per unit area) levels for all cases are less than 0.025 ohm/mm^2^, rendering less than 0.1 ohm of resistance, which is a fraction of the resistance contributed by the flexible printed circuit board (FPCB) ([Fig. 2G](#F2){ref-type="fig"}). This substantially low interconnection resistance can be attributed to the devised implementation of the interconnect, which realizes an effective cross-sectional resistor surface area *A* comparable to the size of the sensor (\~1 mm × 1 mm as compared with conventional interconnects' cross section \~100 nm × 1 mm) and resistor length *l* of 50 μm (as compared with conventional interconnect lengths \~1 cm), representing orders of magnitude of reduction in resistance *R*, where *R* ∝ (*l*/A). Additional characterization results demonstrate minimal changes to the FESS-based interconnection (ACF) resistance, for different bending angles (fig. S7A), upon performing cyclical bending and twisting (over 1000 cycles, respectively shown in fig. S7, B and C) and throughout different daily activities (fig. S7D).

To characterize the mechanical adhesion property of the FESS, 180° peel adhesion tests were performed (as described in detail in Materials and Methods) because interfacial peeling properties are critical to the maintenance of robust interconnection between the FESS and electronics (e.g., PCB). Specifically, the adhesion force between the FESS and electronics should be higher than that between the FESS and dry/actively sweat-secreting skin \[fig. S8; \~0.3 N/cm, in agreement with previously reported skin adhesive medical tape characterization results ([@R29], [@R30])\]. Because the ACF layer in our devised thin film system bridges the FESS structure with electronics, we characterize the force required to peel the ACF layer of the FESS from a PCB. Given the influence of the backing structure (consisting of the microfluidic base and channel) on the peeling profile of the ACF, first, two test device structures were considered and characterized: one with double-sided tape backing (representing the microfluidic base) and one without (representing the microfluidic channel). The peeling forces corresponding to devices with/without backing were characterized as 10.3 and 2.7 N/cm, respectively (\>0.3 N/cm; [Fig. 2, H and I](#F2){ref-type="fig"}). Following the same protocol, a representative FESS (as a complete device structure) containing periodic microfluidic features was also characterized. As shown in [Fig. 2J](#F2){ref-type="fig"}, the measured peeling force profile illustrates a periodic pattern, tracing the interfacial features with and without the microfluidic structure backing, where the maximal and minimal peeling force levels correspond to the peeling forces of the two tested structures in [Fig. 2](#F2){ref-type="fig"} (H and I, respectively). For all characterized test device structures, the peeling forces were greater than 0.3 N/cm, indicating a strong level of the FESS-based interconnection's adhesion to electronics and validating its suitability for on-body applications.

Electrochemical signal transduction
-----------------------------------

In this section, we characterized the signal transduction capability of the FESS. Specifically, to achieve bio/chemical-to-electrical signal transduction, noble metal electrodes were patterned onto the ACF (forming the sensor substrate), followed by the deposition of designated bio/chemical films to target analytes of interest. We first characterized the electrochemical activity of the metal-patterned ACF for two commonly used electrode surfaces: unmodified Au and Pt nanoparticle (PtNP)--modified Au \[which presents enhanced electrocatalytic performance in comparison to unmodified Au ([@R31])\].

Next, cyclic voltammetry was used to test the electrochemical activity of the unmodified Au and Au/PtNP-patterned ACF in 0.1 M H~2~SO~4~ ([Fig. 3, A and B](#F3){ref-type="fig"}), in 0.1 M NaAc (pH 7.2 to 7.8; fig. S9, A and B), and in 0.1 M NaOH (pH 13.0; fig. S9, A and B) solutions ([@R32]). In [Fig. 3A](#F3){ref-type="fig"}, hydrogen evolution reaction can be observed in the cathodic region, where the Au electrode inert potential window extends to \~−0.1 V (versus Ag/AgCl). In the anodic region, the adsorption of anions (i.e., OH^−^ and SO~4~^2−^) and of the initial gold surface oxidation occurs prior to oxygen evolution reaction. The reduction peaks in this region are observed on reverse sweep, which arise from the gold oxide surface reduction and the desorption of ions. The same procedure was performed to characterize the PtNP-modified surface. As shown in [Fig. 3B](#F3){ref-type="fig"}, the electrochemical characteristic of the PtNP-modified surface presents distinct signature peaks, which are related to hydrogen absorption/desorption of a Pt-based surface, indicating successful and stable PtNP modification of the electrode surface. Given the enhanced electrocatalytic activity of the PtNP-modified electrode in comparison to the unmodified Au electrode (fig. S9, C and D), the subsequent electrochemical biosensor development efforts were performed on the PtNP-modified electrode. This property can be exploited to detect electroactive species such as hydrogen peroxide \[H~2~O~2~, sensitivity: 296.2 ± 20.0 μA mM^−1^ cm^−2^, and limit of detection (LOD): 0.2 ± 0.06 μM; [Fig. 3C](#F3){ref-type="fig"}\], ascorbic acid, and dopamine with high sensitivity (fig. S9, E and F). In particular, the highly sensitive detection of H~2~O~2~ (the end-product of numerous enzymatic reactions) can be leveraged for targeting informative biomarkers (e.g., glucose and lactate).The PtNP-modified electrode surface can be functionalized via the deposition of bio/chemical films to equip the FESS with chemo/biosensing capability. Accordingly, the recognition elements of the film as well as the electrochemical interrogation method can be tailored to specifically target the biomarker molecules of interest. For example, [Fig. 3](#F3){ref-type="fig"} (D to F) shows that enzymatic-based sensors can be combined with chronoamperometry to target glucose, lactate, and choline (the corresponding chemical composition of the sensing layer is shown in table S2). In addition, iridium oxide (IrOx)--functionalized electrodes can be combined with open circuit potential (OCP) measurements to measure pH (fig. S9G). These electroanalytical methods provide sample-to-answer biomarker readouts and are capable of rendering real-time insight into the alterations in the sweat bio-composition.

![FESS signal transduction characterization.\
(**A** and **B**) Cyclic voltammetry characterization of Au (A) and Au/PtNP (B) electrode surfaces of the FESS, performed in 0.1 M H~2~SO~4~. Stable operational potential window ([@R29]) is highlighted with the shaded background. (**C** to **F**) FESS-based hydrogen peroxide (C), glucose (D), lactate (E), and choline (F) sensor responses to the target analytes (error bars indicate standard error, *n* = 3). Inset figures show representative amperometric responses. (**G**) Table of common interferents in biofluids (e.g., sweat). (**H** and **I**) Comprehensive selectivity studies for glucose (H) and lactate sensors (I) by monitoring the corresponding sensor responses to the sequential introduction of the listed interferents and target analytes (the introduction time points and the interferents/target analytes are indicated by arrows). (**J**) Characterization of a representative sensor array response built on the FESS platform for multiplex sensing. AA, arachidonic acid.](aaz0007-F3){#F3}

Here, we specifically adapted the sensing capability of the FESS to target glucose, lactate, and choline \[all of which are present in noninvasive biofluids such as sweat ([@R33], [@R34]), as they are informative biomarkers of body metabolism and nutrition ([@R35], [@R36])\]. The sensing interface for each target consists of an enzyme layer, coupled onto a poly-*m*-phenylenediamine (PPD) layer, where the PPD layer serves as a permselective membrane to reject interfering species ([@R37], [@R38]). The response of each sensor toward the target analyte was first characterized individually. [Figure 3](#F3){ref-type="fig"} (D to F) shows the respective current responses of the glucose (sensitivity: 22.8 ± 0.7 μA mM^−1^ cm^−2^ and LOD: 1.7 ± 0.7 μM), lactate (sensitivity: 4.1 ± 0.3 μA mM^−1^ cm^−2^ and LOD: 4.6 ± 3.0 μM), and choline sensors (sensitivity: 9.4 ± 3.9 μA mM^−1^ cm^−2^ and LOD: 10.5 ± 3.7 μM), measured amperometrically within their corresponding physiological relevant range \[glucose: 0 to 1000 μM, lactate: 0 to 20 mM, and choline: 0 to 350 μM, performed in phosphate-buffered saline (PBS)\]. For all three sensors, the generated responses are proportional to the corresponding analyte's concentration levels. To ensure reliable operation in complex biofluids (here, sweat), the selectivity performances of the glucose and lactate sensors were characterized by measuring their responses toward a diverse panel of interfering species. As listed in [Fig. 3G](#F3){ref-type="fig"}, the selected classes of interfering species include the following: electrolytes, electroactive species, drugs, sweat agonists, proteins, and other small molecules. As shown in [Fig. 3](#F3){ref-type="fig"} (H and I), both the glucose and lactate sensors exhibited negligible steady-state responses to the interfering species, while incremental addition of the target analytes' concentration levels caused notable stepwise current responses. The sensing reliability of the FESS was further validated by performing a blind study, where a series of sample solutions were analyzed in random sequence by the FESS (taped onto contact pads) and a gold standard laboratory biochemistry analyzer (YSI 2900D). As shown in fig. S10 (A and B), the biomarker levels measured by the corresponding sensors were very close to those measured by the laboratory instrument (*R*^2^~Gluocse~ = 0.99 and *R*^2^~Lactate~ = 0.95).

Furthermore, to demonstrate the multiplexed sensing capability of the FESS, the developed sensing interfaces were fabricated onto a single ACF, and the resultant functionalized film was taped onto a grid of PCB contact pads. The constructed sensor array's response was continuously monitored while introducing different analytes at different time points. As shown in [Fig. 3J](#F3){ref-type="fig"}, the sequential addition of 1 mM lactate, 100 μM choline, and 100 μM glucose correspondingly resulted in clear and stable stepwise response of the respective sensors. No cross-talk and corrosion-induced noise were observed during the multiplexed measurements. Moreover, amperometry (fig. S11, A to C) and OCP (fig. S11, D and E) characterization experiments validated the electrochemical corrosion resistance of the FESS-PCB in saline solution environments, which is critical to ensure stable and extended sensing operation in biofluids and for the envisioned applications. Additional amperometry measurements performed under thermal cycling (25°, 35°, and 45°C) over an extended time period (\>1 hour) further demonstrated the operational stability of the FESS-PCB system (fig. S11F). The FESS anticorrosion lifetime is estimated to be at least 110 hours at room temperature \[as predicted by the performed accelerated life testing (fig. S11G) and based on the Arrhenius model ([@R39])\].

FESS-enabled smartwatch for sweat biomarker monitoring during daily activities
------------------------------------------------------------------------------

To demonstrate the utility of the FESS for biomarker monitoring during the user's daily activities, the FESS was integrated with a custom-developed smartwatch as a model IoT device ([Fig. 4A](#F4){ref-type="fig"}). The smartwatch hardware consists of analog/digital circuitries, a Bluetooth transceiver, and a liquid crystal display (LCD) screen to implement system-level functionalities such as signal and user command processing, display, and wireless data communication (fig. S12, A to C). Depending on the user's needs, disposable FESS units with different sensing capabilities can be selected and taped onto the smartwatch by leveraging the reversibility of the adhesion forces of the FESS (fig. S12, D to H). The FESS-integrated smartwatch shows similar performance compared with those obtained by the potentiostat (fig. S12I). An optional iontophoresis hardware module (a programmable current source), coupled with a ring-shaped pilocarpine-loaded hydrogel interface, is also implemented as a plugin unit for on-demand sweat induction in sedentary subjects (see more details in Materials and Methods and fig. S12, J and K). The FESS-coupled and lithium polymer--powered hardware is embedded within a form-fitting 3D-printed casing. The complete smartwatch can be adhered onto the skin, without the need for any external wrapping or fixtures, to perform wireless biomarker sensing as a self-contained unit, and the obtained sensing data are linearly correlated with those obtained by a standard potentiostat. While the LCD screen displays the real-time readings and the temporal profile of the biomarker measurements, the Bluetooth transceiver module relays the readings to a custom-developed mobile application, which in turn uploads the data to a cloud-based server for further analysis.

![Custom-developed FESS-integrated smartwatch for on-body application.\
(**A**) Illustration of the FESS-enabled smartwatch (containing FESS, LCD screen, PCB, and battery units housed within a 3D-printed case). (**B** and **C**) Ex situ characterization of the FESS-PCB glucose-sensing system response upon vortical vibration (FESS electrode: 6 mm^2^, microfluidic channel height: 170 μm, and volume: 4 μl). The vibrational acceleration profiles are presented in the top half, and the sensor responses are captured in the bottom half when tested in PBS (B) and 100 μM glucose in PBS (C). (**D** to **G**) On-body signal fidelity characterization of a FESS-PCB lactate-sensing system with a subject performing shadow boxing (D), arm swinging (E), wrist twisting (F), and device pressing (G). The acceleration, frequency, orientation, and force profiles are presented in the top half, and sensor responses are captured in the bottom half. (**H** to **J**) Monitoring the subjects' metabolite profiles through various daily events and in different settings. Iontophoretically induced sweat glucose were measured before and after lunch (H) and dinner (I). (J) Sweat lactate measurements during exercise (a representative motion-induced acceleration profile is shown on the right). (Photo credit: Peterson Nguyen, Kaili Chiu, and Yichao Zhao, University of California, Los Angeles.)](aaz0007-F4){#F4}

To evaluate the signal stability of the FESS-enabled smartwatch against motion artifacts, a series of ex situ and on-body experiments were performed to characterize the sensor response in the presence of varying motion characteristics in terms of frequency, orientation, acceleration, and externally applied contact force. For the ex situ experiments, a FESS-based glucose sensor response was continuously recorded upon introduction of a blank and 100 μM glucose solutions (injected at 5 μl/min to mimic sweat secretion, into a microchannel with the height of 170 μm, containing a 2-mm × 3-mm glucose sensor), under stationary and 3D oscillatory acceleration conditions (\~10 m/s^2^ at 5 Hz, generated by a vortical mixer). As shown in [Fig. 4](#F4){ref-type="fig"} (B and C), the measured sensor responses exhibit negligible fluctuations (\<6%) despite the induced motion, indicating the high fidelity of data achieved by the FESS-based system (similarly, as shown in Fig. S13, stable responses were recorded for the microfluidic sensing modules with different channel heights and sensor dimensions, as well as the insufficient fluidic filling situation). Furthermore, for on-body characterization, a FESS-based lactate sensor was integrated with the smartwatch worn by the subject, and then the sensor's response to exercise-induced sweat was continuously recorded under various body motions, including punching, arm swinging, and forearm twisting, with varying acceleration, frequency, and orientation. In addition, to quantify the effect of varying externally applied contact forces, different weights \[1 to 2 N, similar force levels to that applied during finger tapping ([@R40])\] were applied to the smartwatch during the on-body, lactate sensor response recordings. As shown in [Fig. 4](#F4){ref-type="fig"} (D to G), the measured sensor responses across all conditions exhibit negligible fluctuations (\<8%), indicating the suitability of the FESS-based smartwatch to render high-fidelity biomarker data recording in the presence of unconstrained body motion.

To demonstrate the utility of the wearable system for the envisioned diurnal and longitudinal biomarker monitoring, the FESS-enabled smartwatch was adhered on a subject's forearm, which was wirelessly controlled by the subject to take real-time sweat-based biomarker measurements at set time intervals in relation to the user's daily routine. The smartwatch was used by the subject to monitor his iontophoretically induced sweat glucose levels before/after the consumption of mixed meals (e.g., at the user's routine lunch and dinner times). As illustrated in [Fig. 4](#F4){ref-type="fig"} (H and I), the smartwatch glucose sensor readouts indicate the elevation of the subject's sweat glucose level upon food intake, which is in line with previously reported trends ([@R41]). In addition, the smartwatch was used by the subject to monitor the sweat lactate profile ([Fig. 4J](#F4){ref-type="fig"}) during running in a field. The smartwatch readouts indicated stable sweat lactate readings, despite the presence of relatively high-frequency and high-acceleration body motions involved in the running session.

DISCUSSION
==========

Here, by examining the biomarker information delivery pathway and recognizing near-zero strained regions within a microfluidic-based sensing module, we engineered a strain-isolated pathway to preserve the biomarker data fidelity. To render an efficient implementation, inspired by integrin (a cell adhesive molecule), which facilitates physiological information exchange between biological interfaces via sensing, out-of-plane signal interconnection, and double-sided adhesion forces, a generalizable and disposable electrochemical thin film sensing system is devised. The thin film system renders integrin-like functionalities in terms of signal transduction and coaxial signal interconnection/double-sided adhesion forces, all within a freestanding entity (namely, FESS). The FESS can reliably bridge the skin and the readout electronics to harvest biomarker information. The FESS also serves as a foundation to realize an unprecedented system-level design strategy to simultaneously address the challenges of wearable biosensing and integration with consumer electronics for daily use. To illustrate this objective, the FESS is seamlessly coupled with a custom-developed smartwatch. The robustness of the FESS-enabled smartwatch was validated by monitoring the real-time biomarker readouts throughout the user's daily routine activities. The versatility of the FESS can be exploited to target a wide panel of biomarkers. The design methodology can be equivalently adopted to construct physical sensing interfaces in order to characterize the informative metrics related to the sweat secretion profile (e.g., the onset of sweating, secretion rate, and sweat loss volume). The inclusion of such interfaces can be particularly useful for devising correction mechanisms toward mitigating the confounding effect of inter-/intrasubject physiological variations and gland activity variability (in terms of metabolism and secretion rate), which have been reported to distort the physiological significance of the raw sweat readings ([@R35], [@R36], [@R42]--[@R44]).

Ultimately, to commercialize and adapt the presented wearable technology for population-level health and wellness monitoring, future clinical trials are required to map the sweat-based biomarker readings to the physiological status of the users, while accounting for the biological factors such as inter/intraindividual and anatomical variations. In that regard, the advantages of our technology in terms of its ease of integration with wearable consumer electronics and its ability to generate high-fidelity biomarker readings can be particularly harnessed to perform large-scale and longitudinal clinical investigations. The large datasets rendered by such studies enable the physiological meaningful interpretation of the biomarker readings and the establishment of the objective criteria necessary to provide actionable feedback to the users.

MATERIALS AND METHODS
=====================

Fabrication process of the FESS
-------------------------------

The FESS, a thin film system, consists of multiple vertically stacked films: (i) a double-sided adhesive ACF (9703, 3M, 50 μm, ACF), (ii) a noble metal electrode array patterned on ACF, (iii) a bioanalytical film deposited on the electrodes as a sensing interface, (iv) a thin film microfluidic structure that houses biosensors, and (v) a double-sided skin adhesive film that facilitates the adherence of the FESS's microfluidic module to the skin. The fabrication process of the FESS is as follows:

1\. Electrode array patterning and characterization on ACF. First, an ACF was used as the substrate for electrode array patterning. One of the adhesive surfaces was covered with a prepatterned mask for metal deposition. A 200-nm-thick Au layer was thermally deposited onto the ACF to create an Au electrode array. For the Pt-based electrode array, PtNPs were deposited onto the Au electrodes by chemical reduction in an aqueous solution of 2.5 mM H~2~PtCl~6~ and 1.5 mM formic acid (−0.1 V versus Ag/AgCl, 10 min) to construct the PtNP-coated Au electrodes (Au/PtNP) ([@R45]). Cyclic voltammetry was used to examine their cathodic and anodic currents (under a three-electrode system) using a potentiostat (CHI660E, CH Instruments, USA). The experiments were performed in fresh 0.1 M H~2~SO~4~ solution/0.1 M NaAc/0.1 M NaOH solution, and the potential was scanned at a rate of 25 mV/s.

2\. Biosensing interface construction. A PPD layer was electrochemically deposited onto the Au/PtNP electrodes by applying 0.85 V (versus Ag/AgCl) for 300 s in a fresh PBS solution (pH 7.2; Gibco PBS, Thermo Fisher Scientific) with 5 mM *m*-phenylenediamine (Sigma-Aldrich). Then, the Au/PtNP/PPD electrodes were washed with deionized (DI) water and air dried. Next, the electrode array was transferred to a low-adhesion release paper liner (72\#, 3M) by using polyvinyl alcohol (PVA) water-soluble tape (5414, 3M) and rinsed in DI water to remove residual particles. A 1% chitosan solution (Sigma-Aldrich) was prepared by dissolving chitosan in a 2% acetic acid (Sigma-Aldrich) solution by heating it up to 60°C for 30 min until chitosan was fully dissolved. To develop the glucose sensor, the aforementioned 1% chitosan solution was mixed thoroughly with a glucose oxidase solution (50 mg/ml in PBS, pH 7.2; Sigma-Aldrich\] at a ratio of 1:1 (v/v). By drop casting 1 μl of the mixture onto the Au/PtNP/PPD electrode (12 mm^2^), the glucose-sensing interface was realized. To create the choline sensor, a 0.5-μl choline oxidase solution (0.5 U/μl in DI water, pH 7.2; Sigma-Aldrich) was placed onto the Au/Pt/PPD electrode (12 mm^2^), dried at room temperature, and was followed by drop casting a 0.5-μl 1% chitosan solution. To create the lactate sensor, a 4-μl lactate oxidase solution (50 mg/ml in PBS; Toyobo) was deposited onto Au/PtNP/PPD electrode (12 mm^2^) and dried at room temperature, followed by drop casting of a 2-μl 1% chitosan solution and a 2-μl 3% polyvinyl chloride (Sigma-Aldrich) solution ([@R46]). The sensors were allowed to dry overnight at 4°C while being protected from light. They were stored at 4°C when not in use. For pH sensor, IrOx was electrodeposited following previously reported protocols ([@R47], [@R48]). For all biosensors, the reference electrode was fabricated by depositing Ag/AgCl ink (Ercon) on the electrodes and heating the modified electrodes at 80°C for 10 min. The Au/PtNP electrode was used as the counter electrode.

3\. Microfluidic module assembly. Microfluidic channels were created by laser cutting (Epilog Mini 24, Epilog Laser) 2D patterns on the double-sided tape (\~170 μm). By laser patterning holes on polyethylene terephthalate (PET; \~100 μm; MG Chemicals), outlet features were created to facilitate an ejection path for the sampled biofluid. The microfluidic structure/module was then assembled by attaching the patterned PET layer to the patterned double-sided tape with proper alignment, such that the filling of the microfluidic channel results in the coverage of the working electrode first and then the reference electrode. In this way, it is ensured that the working electrode with predefined surface area is fully covered when the electrical signal appears upon the establishment of the fluid connection between the two electrodes. The microfluidic structure served as the strain-isolated housing for all biosensors (constructed on ACF).

Finite element analysis and mechanical modeling of the FESS
-----------------------------------------------------------

Finite element analysis (FEA) software, COMSOL 5.2, was used to simulate the mechanical behavior of the FESS under the directional shear load expected during usage. A 3D model of the FESS, mounted on the readout electronics, was used for the mechanical analysis with no delamination between layers being considered. In-plane directional shear force was applied on the skin adhesive layer with the base of electronics fixed. Similarly, the strain profile of the conventional in-plane interconnection subjected to a directional shear load and a bidirectional stretch load was analyzed using a 2D demo structure. For directional shearing, 10% displacement along the skin surface was applied on the μ-fluidics structure interfacing the skin, and the displacement of the readout electronics was set to zero. For bidirectional stretching, displacements corresponding to 10% skin stretching were applied on both the readout electronics and the μ-fluidics interfacing the skin. The strain distributions and magnitudes were captured for each simulation. The Young's modulus and Poisson's ratio used in the simulations were as follows: 450 MPa and 0.49 for the ACF, skin adhesive, and μ-fluidics structure; 2.5 GPa and 0.4 for PET; 24 GPa and 0.12 for the rigid electronics (flame retardant-4); 2.5 GPa and 0.4 for flexible electronics (PI); and 500 kPa and 0.49 for stretchable electronics (PDMS).

Contact resistance measurement of the FESS
------------------------------------------

The electrical resistance between the ENIG (electroless nickel/immersion gold) contact pads (6 × 6 array, on a FPCB) and their corresponding pins were measured and recorded by a multimeter (Fluke-299), as initial resistances. Then, an ACF layer patterned with corresponding 6 × 6 Au electrode array was transferred onto the ENIG contact pads with proper alignment. The ACF-FPCB was mounted onto the curved surface of a 3D-printed holder. The resistance for each pixel of the Au array on ACF was measured again by the same multimeter. Each resistance value was determined by averaging measured resistances from three different positions of the electrode surface.

Peel adhesion test of the FESS
------------------------------

The peel adhesion force (interfacial toughness) between the FESS and the PCB was determined by performing standard 180° peeling tests, based on American Society for Testing and Materials (ASTM) D3330, with a mechanical testing machine (Instron 5943). At first, the ACF, microfluidic channel--patterned double-sided tape, and PET were laser cut and assembled into 30-mm-wide and 300-mm-long strips. The patterned double-sided tape and PET served as the microfluidic structure, which can be considered as the backing material for the ACF. During the test, the ACF side of the laminated FESS strip was thumb pressed onto the PCB to ensure a uniform and tight bond. The samples were prepared in less than 1 day prior to the mechanical tests. The peeling tests were performed with the standard 180° peeling method at a speed of 5 mm/s in ambient air at room temperature. The force versus displacement profile was directly output by the Instron, and the peeling adhesion force/interfacial toughness was calculated by dividing the measured peeling force by the sample width.

Biosensor characterization and analytes measurement
---------------------------------------------------

To characterize the developed enzymatic sensing interfaces, constant potential amperometric measurements were conducted in PBS buffer (pH 7.2) at +0.5 V versus Ag/AgCl. The amperometric response was continuously recorded by a potentiostat under constant stirring. By stepwise addition of different concentrations of the target analytes (e.g., glucose, lactate, and choline) in the PBS buffer for different sensors, a series of calibration plots were obtained. The LOD for each amperometric sensing interface was calculated as LOD = 3\*SD/(slope of calibration curve), where SD is the standard deviation of the baseline noise in blank solution. To characterize the IrOx pH sensor, OCP was measured against a separate Ag/AgCl reference. The PBS was titrated with NaOH/HCl to vary the pH from 4.1 to 10.15, and each stabilized OCP was recorded. The sensor selectivity tests were performed by the stepwise addition of different interferents into PBS, including glucose/lactate, creatine, KCl, NaCl, uric acid, ascorbic acid, pilocarpine, aspirin, metformin, and albumin. At the end of the selectivity test, the target analytes were also added into the solutions.

Anticorrosion capability of the FESS-PCB
----------------------------------------

Two PCBs with ENIG-based electrodes (18 mm^2^) and a Pt disk electrode (1.6 mm in diameter) were cleaned with DI water and isopropyl alcohol solution and then dried in air at room temperature. The ACF with Au/PtNP was transferred and aligned with the electrodes on one PCB, and the other PCB was left unmodified as a control. The unmodified PCB, PCB with Au/PtNP-patterned ACF, and Pt disk electrode were immersed into a PBS solution followed by OCP and corrosion current measurements. For OCP measurement, the voltage was recorded using a potentiostat. For corrosion current measurement, + 0.5 V (versus Ag/AgCl) was applied under constant stirring.

Ex situ signal fidelity characterization of the FESS-PCB
--------------------------------------------------------

The FESS-PCB system and an accelerometer (mobile phone) were fixed onto a vortex mixer (Fisher Scientific). The blank PBS and PBS containing 100 μM glucose were sequentially injected into the FESS with a controlled flow rate (5 μl/min). The electrochemical signal was then recorded by a potentiostat during stationary and motion-induced (via vortex mixer, frequency = 5 Hz) conditions.

On-body test using the FESS-integrated smartwatch
-------------------------------------------------

The FESS was transferred onto the contact pads located on the backside of the custom-developed smartwatch. Then, the FESS-coupled smartwatch was adhered onto a healthy human participant's wrist. A smartwatch case was designed and 3D printed to consolidate the smartwatch components (including LCD display, PCB module, and battery). In addition to the smartwatch, a mobile phone (equipped with an accelerometer) was mounted onto the subject's forearm to record the acceleration of his forearm during the exercise. To induce sweat iontophoretically, the target stimulation area of the skin was first cleaned with DI water and ethanol, followed by 5 min of iontophoretic sweat gland stimulation (with pilocarpine-loaded hydrogels, Pilogel).

Wireless PCB module
-------------------

The wireless PCB module implements the required sweat stimulation circuitries to drive the iontophoresis electrode, as well as signal conditioning and processing circuitries to reliably measure the transduced sensing signals. The electrical connections from the iontophoresis/sensing layers with the main board were established by the metal vias, embedded within each layer. At its core, the PCB used an ultra-low-power microcontroller unit (STM8L--UFQFN20, STMicroelectronics), which was programmed to facilitate system-level functionalities. These functionalities include setting the current levels for iontophoresis (accompanied with a current limiting protection circuitry) and providing I2C-controlled signals for the sensing and serial data communication modules. The microcontroller is interfaced with an onboard Bluetooth transceiver to wirelessly and bilaterally communicate the command and sensor output data with a custom-developed smartphone application. Moreover, the microcontroller communicates with an onboard LCD screen (st7735--TFT-LCD, Sitronix Technology Corporation) to display the biomarker readouts, iontophoresis current level, and the local time.

An analog signal acquisition and conditioning circuitry was developed to interface the amperometric sensors and process the transduced signals. Accordingly, after the sensing mode is activated, an LMP91000 potentiostat chip (Texas Instruments) was enabled. This chip was programmed to maintain +0.5 V across the working and reference electrodes and to convert the transduced sensor current to voltage values by leveraging its internal transimpedance amplifier stage. The output of the potentiostat was connected to a fifth-order low-pass filter (LPF), which was realized by a MAX7422 chip (Maxim Integrated), with a cutoff frequency of 1 Hz. The LPF stage mitigates the high-frequency interference and the user's motion artifacts. The microcontroller's built-in 12-bit analog-to-digital unit was used to convert the LPF's analog output to the digital domain. The measured amperometric sensor response by the PCB was validated against a potentiostat.

In our PCB development efforts, we selected integrated circuit chips that were designed for low-power/ultra-low-power applications to implement a power-efficient system. To power the PCB, a single, miniaturized, rechargeable lithium-ion polymer battery with a nominal voltage of 3.7 V was used. The choice for the battery's capacity depends on the intended modes and duration of operations. On the basis of our characterization results, with no further power optimization, the envisioned simultaneous operations (e.g., iontophoresis, sensing, and bilateral wireless communication) demanded peak supply current levels on the order of 100 mA. For an application such as periodic sweat sampling and analysis at six points during the day (e.g., monitoring glucose levels before/after main meals), and assuming 15 min of active operation, a battery capacity on the order of 500 mAh would be sufficient.

Smartphone application and smartwatch design
--------------------------------------------

To wirelessly communicate with the PCB module from the user standpoint, an Android-based smartphone application was developed. The application provides a graphical user interface to execute a range of functionalities, including setting the desired operational modes as well as data display and storage. In our implementation, the user input is read and relayed to the PCB through Bluetooth communication of predefined integer values (each value mapped to a desired operation). Then, the corresponding command is received and executed at the microcontroller level.

The custom smartphone application design/cloud server
-----------------------------------------------------

The Android application is designed to establish communication with the paired/specified custom-developed smartwatch upon startup. Once the communication is established, the user has the option to program the desired iontophoresis current level for sweat stimulation. In addition, the user can switch between the iontophoresis and sensing modes with the press of a button. In sensing mode, the real-time and filtered sensing results are recorded, timestamped, and plotted by the application. Last, the sweat metabolite data captured by the application are automatically stored on a custom-developed Google Cloud platform.

IRB approval for human subject testing
--------------------------------------

The conducted human subject experiments were performed in compliance with the protocols approved by the Institutional Review Board (IRB) at the University of California, Los Angeles (IRB no. 17-000170). All subjects gave written informed consent before participation in the study.
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